Coldrex Broncho

Coldrex Broncho is a medicine manufactured in the UK by the pharmaceutical company GlaxoSmithKline Consumer Healthcare and manufactured by Rafton Laboratories Limited and Smithkline Beach. It belongs to the group of expectorant stimulants and contains guaifenesin as an active substance.

Coldrex Broncho is available as a syrup containing 20 mg of guaifenesin per ml. It is used to facilitate the discharge of sputum in chronic bronchitis, tracheitis, bronchial asthma, sinusitis and pharyngitis.

Despite the positive effect, Coldrex "Broncho" has a number of contraindications. It is not recommended for people with hypersensitivity to guaifenesin, as well as for peptic ulcers of the stomach and duodenum in the acute stage and in case of a wet cough with an abundance of sputum.

When using Coldrex Broncho, side effects may occur, such as discomfort in the stomach, nausea, vomiting, diarrhea and drowsiness. These effects may be enhanced when taking high doses.

In addition, before using Coldrex Broncho, it is necessary to consider the possibility of interaction with other drugs, such as antitussives, sympathomimetics and bronchodilators, including phosphodiesterase inhibitors.

Finally, you should pay attention to the possibility of overdose when using Coldrex "Broncho", which can lead to increased adverse reactions. The use of the drug during pregnancy and lactation should be carried out only if there are vital indications and under the supervision of a physician.

Thus, Coldrex "Broncho" is an effective remedy for facilitating sputum discharge in a number of respiratory tract diseases. However, before using it, it is necessary to take into account contraindications and possible side effects, and also consult a doctor.